
Kallisio expands patient access to 3D-printed intraoral devices for head and neck cancer radiation therapy patients
Stentra has been cleared by the U.S. Food and Drug Administration (FDA 510(k) K232293) and is in clinical use at leading U.S. cancer centres, including a recently announced collaboration with Stanford Health Care.
Article opens at the original publisher in a new tab. We link, we don’t mirror.





